While O2 sensors have no fixed replacement schedule, your driving style and the health of other engine components can ...

OTC glucose monitors are moving into wearable health tech, but the clearest benefits remain for diabetes and prediabetes ...

I'm Larry Biegelsen, the Medical Device Analyst at Wells Fargo. Welcome to the final call in our 2026 MedTech Innovation Spotlight Series. I'm pleased to be joined by Inspire Medical's management team ...

In the neonatal intensive care unit, the most fragile patients in medicine are often the most heavily wired. Premature babies, some weighing less than a pound, can be tethered to a tangle of cables, ...

Ultrahuman M2 Live brings no-prescription glucose tracking to the US using Abbott’s Lingo CGM, with plans starting at $99 per ...

Using a portable sensor, the technology analyzes exhaled biomarkers to detect lung conditions without a lab test or chest ...

Ultrahuman has expanded its digital health ecosystem with the US launch of M2 Live, an updated metabolic health platform that integrates continuous glucose data from Abbott’s over-the-counter Lingo ...

Google Health’s work to address issues and make improvements to the redesigned Android and iOS app continues today with version 5.02. Update 6/22: Google Health 5.02 is now widely rolling out on ...

A good smart scale for US users, though it has a few annoying hiccups. The handle-based design and lifetime warranty make ...

The ATOM DX encoder is built on the optical system platform of the market-proven ATOM ™ encoder. It integrates Renishaw's ...

The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.